Translational Breast Cancer Research
AME Publishing Company · Hong Kong · Est. 2020
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1 · Scopus CiteScore 3.4. Source: Clarivate Journal Citation Reports.
Aims & Scope
Translational Breast Cancer Research (TBCR) is an open access journal that publishes original research, reviews, commentaries, and expert consensus articles on all aspects of breast cancer, with a focus on translational research. The journal aims to bridge the gap between basic science and clinical practice, promoting the rapid translation of laboratory discoveries into clinical applications. TBCR covers a wide range of topics including breast cancer biology, diagnosis, treatment, prevention, and survivorship. The journal is committed to publishing high-quality, impactful research that advances the understanding and management of breast cancer.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Translational Breast Cancer Research
Is Translational Breast Cancer Research a predatory journal?
PubScope has no integrity flags on record for Translational Breast Cancer Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Translational Breast Cancer Research?
Translational Breast Cancer Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 3.4.
Is Translational Breast Cancer Research indexed in Scopus and Web of Science?
Translational Breast Cancer Research is indexed in Web of Science, Scopus.
What is the aims and scope of Translational Breast Cancer Research?
Translational Breast Cancer Research (TBCR) is an open access journal that publishes original research, reviews, commentaries, and expert consensus articles on all aspects of breast cancer, with a focus on translational research. The journal aims to bridge the gap between basic science and clinical practice, promoting the rapid translation of laboratory discoveries into clinical applications. TBCR covers a wide range of topics including breast cancer biology, diagnosis, treatment, prevention, and survivorship. The journal is committed to publishing high-quality, impactful research that advance
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref